Stay updated on Efficacy and Safety of MV130 in COPD Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of MV130 in COPD Clinical Trial page.

Latest updates to the Efficacy and Safety of MV130 in COPD Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now includes a Locations section listing Barcelona and Madrid as sites, while the separate Barcelona/Madrid Locations subsections were removed; the revision updated from v3.3.2 to v3.3.3.SummaryDifference0.3%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page shows a minor revision label update (from v3.3.1 to v3.3.2) with no changes to study content or data. No core content, eligibility criteria, endpoints, or location details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the site-wide notice about funding status, while the MV130 COPD trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedAdministrative metadata (results posting date and last update) was updated, while the core study content remains unchanged.SummaryDifference0.4%

- Check94 days agoChange DetectedSummary of changes: the page now presents updated trial details for MV130 in COPD, including design, endpoints, dosing, eligibility, sites, and current/expected results posting timelines, replacing older status language.SummaryDifference100%

Stay in the know with updates to Efficacy and Safety of MV130 in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of MV130 in COPD Clinical Trial page.